Target intelligence / Profile preview

Usher syndrome type 2A pre-messenger RNA exon 13 region (USH2A pre-mRNA exon 13) (USH2A pre-mRNA exon 13)

Target
USH2A pre-mRNA exon 13
Molecular classification
Pre-messenger RNA, Nucleic acid
01

Overview

The Usher syndrome type 2A (USH2A) pre-messenger RNA exon 13 region is a critical segment of the USH2A transcript that encodes a portion of the usherin protein. Usherin is a large basement membrane-like protein located in the connecting cilia of photoreceptors and the hair cell bundle of the inner ear, where it is vital for structural integrity and sensory function (UniProt: O75445). Mutations in exon 13, most notably the c.2299delG frameshift mutation, are among the most frequent causes of Usher syndrome type 2A and autosomal recessive retinitis pigmentosa (NCBI Gene: 7399). This specific RNA region is targeted by antisense oligonucleotides (ASOs) like ulrevorsen (QR-421a) to modulate the splicing process. These therapeutic agents bind to the pre-mRNA and mask the splice sites of exon 13, causing the cellular machinery to skip this exon (Dulla et al., 2021, Molecular Therapy - Nucleic Acids). Because exon 13 contains an even number of nucleotides, its removal maintains the reading frame, leading to the production of a shortened but functional usherin protein that can mitigate the degenerative effects of the disease.

Other names
USH2A exon 13Usherin pre-mRNA exon 13USH2A pre-messenger RNA exon 13
02

Mechanism of action

Antisense oligonucleotide-mediated exon skipping to exclude the mutation-bearing exon 13 from the mature mRNA, restoring the reading frame and producing a functional truncated usherin protein.

03

Biological functions

RNA splicingSensory perception of soundVisual perception
04

Disease associations

Usher syndrome type 2ARetinitis pigmentosa
05

Safety considerations

Intravitreal injection-related complicationsPotential off-target RNA bindingLocal ocular inflammation
06

Interacting drugs

Ulrevorsen

1 more in the full profile.

07

Biomarkers

c.2299delG mutationc.2270C>G mutationEllipsoid zone (EZ) areaBest-corrected visual acuity (BCVA)

Beyond the preview

Go deeper on Usher syndrome type 2A pre-messenger RNA exon 13 region (USH2A pre-mRNA exon 13) (USH2A pre-mRNA exon 13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Usher syndrome type 2A pre-messenger RNA exon 13 region (USH2A pre-mRNA exon 13) (USH2A pre-mRNA exon 13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call